Financial crisis causes shift in EU drug pricing, GlobalData says

08/22/2012 | PharmaTimes (U.K.)

Europe's financial crisis is resulting in a continual shift in drug pricing, according to GlobalData. Governments are cutting health care expenses to deal with the sovereign-debt crisis. The biggest issue confronting the drug sector "is renewed pricing pressure from all directions," said Michael Leibfried, GlobalData's senior analyst for health care industry dynamics.

View Full Article in:

PharmaTimes (U.K.)